Marco Tuccori was born in Lucca (Italy) in 1976. In 2001, he graduated with Honors at the School of Pharmacy of the University of Pisa. From 2002 to 2005, he attended the Post Graduate School of Pharmacology at the University of Pisa. He achieved the PhD in Pharmacology and Medical Physiology at the University of Pisa in 2010 with a project of research on the risk of progressive multifocal leukoencephalopathy in non-Hodgkin lymphoma patients receiving rituximab. In August 2009 he started to work as Pharmacist Head at the Unit of Clinical Pharmacology at the University Hospital of Pisa. Since March 2012 he has been employed as Pharmacovigilance Manager at the Unit of Adverse Drug Reactions Monitoring of the University Hospital of Pisa. He is currently one of the coordinators of the Tuscan Regional Centre of Pharmacovigilance and collaborates with the Agenzia Italiana del Farmaco (AIFA) as member of the Working Group for Signal Detection Analysis on Drugs and Vaccines. He is free-of-charge professor of Pharmacovigilance and Evidence Based Medicine at the department of Pharmacy of the University of Pisa. He is currently in charge of several courses of Pharmacology, Pharmacovigilance and Pharmacoepidemiology at the post-graduate school (specialization) of Pharmacology, Gastroeneterology, Otolaryngology and Traumatology at the University of Pisa. He was a member of the advisory board of the International society of Pharmacovigilance (ISoP) from 2012 to 2019. In 2015 he attended a post-doc fellowship at the Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, McGill University (Montreal, Canada). Since 2022 he is co-chair of the Scientific Board of the ISoP. He is the author of about 100 articles in peer reviewed scientific journals and 4 chapters on books.